Real-world survival of relapsed compared to de-novo stage IV diagnosis of advanced non-small cell lung cancer Published September 2019 Citation Kerrigan, KC, Halland, B, Adamson, BJS, Patel, SB, Akerley, WL. . World Conference on Lung Cancer. . https://wclc2019.iaslc.org/wp-content/uploads/2019/08/WCLC2019-Abstract-Book_web-friendly.pdf#page=328 Authors:Kerrigan, KC, Halland, B, Adamson, BJS, Patel, SB, Akerley, WL Sources:World Conference on Lung Cancer Share Posted inPublicationsUnmet needNon-small cell lung cancer More publicationsISPORApril 2026Impact of telemedicine encounters on survival outcomes in advanced lung cancer: A time-varying cox analysis using EHR-derived dataParatane D, Adamson B, Zemplenyi APublication summaryPublicationsNon-small cell lung cancerISPORApril 2026From real-world data (RWD) to digital twins: building models for patient-level counterfactual prediction in oncologyGriffith S, Manfredonia J, Ricottone M, et al.Publication summaryPublicationsMachine learningNon-small cell lung cancerArtificial intelligenceJCO Cancer Clinical InformaticsMarch 2026Impact of real-world response to first-line immunotherapy and chemotherapy on subsequent treatment outcomes in patients with advanced or metastatic non-small cell lung cancerMalhotra J, Viswanathan S, Mhatre S, et al. Publication summaryPublicationsTreatment patternsNon-small cell lung cancer